Maury Raycroft

Stock Analyst at Jefferies

(0)
# 4728
Out of 5,441 analysts
80
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
42 Stocks
Name Action PT Current % Upside Ratings Updated
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
328 384
434.89 -11.7% 2 Jul 7, 2025
CRDF Cardiff Oncology
Initiates Coverage On: Hold
4
2.33 50.21% 1 Jun 24, 2025
CRBP Corbus Pharmaceutica...
Maintains: Buy
70 53
8.67 511.3% 2 Mar 11, 2025
CMRX Chimerix
Downgrades: Hold
10 9
8.54 -0.47% 2 Mar 5, 2025
CMPX Compass Therapeutics
Maintains: Strong Buy
7 8
3.33 140.24% 2 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 3
n/a n/a 1 Dec 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.51 363.58% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.48 305.41% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Strong Buy
16 17
4 325% 1 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
6.42 195.95% 1 Jul 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
58 39
40 -2.5% 2 May 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
23 15
3.51 327.35% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 39
18.93 106.02% 2 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.84 614.29% 1 Mar 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.81 1170.72% 1 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
195
8.02 2331.42% 1 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 58
58.7 -1.19% 7 Oct 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
11
8.2 34.15% 8 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
104 173
172.36 0.08% 3 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4 2
1.02 47.06% 1 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
6 9
n/a n/a 2 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32 6
20.18 -70.27% 2 Jan 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 75
17.2 336.05% 4 Nov 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 36
36.01 -0.03% 2 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
5.93 85.5% 1 Sep 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 20
20.01 -0.05% 1 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
39 55
54.99 0.02% 1 Apr 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
31 27
10.1 167.33% 3 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
38 5
2.05 143.9% 2 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 17
0.53 3107.55% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
4.07 465.11% 1 Nov 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
46.7 2.78% 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
0.6 53233.33% 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
8.5 323.53% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
105
6.06 1632.67% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
172
55.44 210.25% 2 Apr 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
10.5 109.52% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
47
2.29 1952.4% 1 Feb 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 2
n/a n/a 2 Jan 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
18 40
n/a n/a 5 Aug 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
230
3.93 5752.42% 1 Jul 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 42
10.75 290.7% 3 Nov 1, 2017